Kunwar Shailubhai
Corporate Officer/Principal bei Baruch S. Blumberg Institute
Profil
Kunwar Shailubhai is the founder of Synergy Pharmaceuticals LLC, which was founded in 2001.
He held the position of Chief Scientific Officer & Executive VP from 2008 to 2017.
Currently, he is a Professor at Baruch S.
Blumberg Institute.
Dr. Shailubhai's former jobs include being a Non-Executive Director at OKYO Pharma Ltd.
from 2017 to 2021, a Director at Active With Me, Inc., an Executive Director at Tiziana Life Sciences Ltd.
(United Kingdom) in 2022, an Executive Director at Actavia Life Sciences, Inc. in 2020, and a Vice President-Drug Discovery at Callisto Pharmaceuticals, Inc. from 2001 to 2004.
He was also a Chief Scientific Officer at Pawfect Foods, Inc. and a Senior Vice President at Drug Discovery Facility from 2003 to 2008.
Additionally, he was an Assistant Professor at the University of Maryland and the Chief Executive & Scientific Officer at Tiziana Life Sciences Ltd.
Dr. Shailubhai received an MBA degree from the University of Missouri in 2002 and a doctorate degree from the University of Baroda in 1984.
Aktive Positionen von Kunwar Shailubhai
| Unternehmen | Position | Beginn |
|---|---|---|
| Baruch S. Blumberg Institute | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Kunwar Shailubhai
| Unternehmen | Position | Ende |
|---|---|---|
| TIZIANA LIFE SCIENCES LTD | Chief Executive Officer | 01.08.2022 |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Chief Executive Officer | - |
| ACCUSTEM SCIENCES, INC. | Director/Board Member | 20.06.2022 |
| OKYO PHARMA LIMITED | Director/Board Member | 17.06.2021 |
| ACTAVIA LIFE SCIENCES, INC. | Chief Executive Officer | 06.02.2020 |
Ausbildung von Kunwar Shailubhai
| University of Missouri | Masters Business Admin |
| University of Baroda | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| OKYO PHARMA LIMITED | Health Technology |
| ACTAVIA LIFE SCIENCES, INC. | Health Technology |
| ACCUSTEM SCIENCES, INC. | Health Technology |
| TIZIANA LIFE SCIENCES LTD | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Health Technology |
| Pawfect Foods, Inc. | Retail Trade |
Active With Me, Inc.
 Active With Me, Inc. Miscellaneous Commercial ServicesCommercial Services Active With Me, Inc. provides online resources that seamlessly offer travelers unique, highly relevant and user-friendly information on activity-based travel. Its listings will be provided for product and service providers of interest to the activity-based traveler. The company was founded on December 6, 2012 and is headquartered in Sarnia, Canada. | Commercial Services |
Drug Discovery Facility
 Drug Discovery Facility Pharmaceuticals: MajorHealth Technology Part of SCYNEXIS, Inc., Drug Discovery Facility provides research into drug-discovery processes. The private company is based in Cambridge, UK. Drug Discovery Facility was acquired by SCYNEXIS, Inc. from Aventis Cropscience on October 02, 2001. | Health Technology |
| Baruch S. Blumberg Institute | |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Health Technology |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
